Evidence map›Paper›PMID 32961543›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

A potential biomarker for treatment stratification in psychosis: evaluation of an [

Mattia Veronese, Barbara Santangelo, Sameer Jauhar, Enrico D'Ambrosio, Arsime Demjaha, Hugh Salimbeni, Jin Huajie, Paul McCrone, Federico Turkheimer, Oliver Howes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Radiomic Analysis of Striatal [Molecular imaging and biology · 2025
    Article
  11. Review
  12. The hypothesis of biologically based subtypes of schizophrenia: a 10-year update.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  13. Complex Diagnostic Challenges in Glioblastoma: The Role ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
  14. Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. An automatic analysis framework for FDOPA PET neuroimaging.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mattia Veronese *Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. mattia.veronese@kcl.ac.uk.ORCID http://orcid.org/0000-0003-3562-0683
Barbara Santangelo *Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Sameer JauharDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-3878-3659
Enrico D'AmbrosioDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0001-9774-3860
Arsime DemjahaDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Hugh SalimbeniFaculty of Engineering, Department of Computing, Imperial College London, South Kensington Campus, London, UK.
Jin HuajieKing's Health Economics, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-3872-3998
Paul McCroneFaculty of Education, Health and Human Sciences, University of Greenwich, London, UK.
Federico TurkheimerDepartment of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Oliver HowesDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. oliver.howes@kcl.ac.uk.ORCID http://orcid.org/0000-0002-2928-1972

Funding

Medical Research Council MC_U120097115
6 · The paper itself

Abstract

[

Indexed as

DihydroxyphenylalaninePsychotic DisordersBiomarkersHumansPositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsBiomarkersDihydroxyphenylalanineRadiopharmaceuticals

Identifiers

PMID32961543
PMCPMC8115068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.